Prostate cancer drugs' safety in question.  Links with heart disease and diabetes have resulted in FDA review of the drugs' safety.
D016588:Anticarcinogenic Agents / Q000009:adverse effects* / Q000592:standards*; D003920:Diabetes Mellitus / Q000139:chemically induced; D017277:Drug Approval; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000502:physiology
D016588:Anticarcinogenic Agents; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone